However, NDRG1 overexpression led to reduced proliferation in estrogen receptor-positive (ER+) MCF7 cells, while having the opposite effect in triple-negative breast cancer (TNBC) cells, indicating a cell type-dependent response. This evidence concerns the gene NDRG1 and triple-negative breast carcinoma.